16 Results Found
MSD Merck Sharp & Dohme Opens Global Innovation and Development Hub to ‘The Circle’ in Zurich
Go to all press releases Zurich, December 9, 2021 – MSD Merck Sharp & Dohme AG known as Merck & Co, Inc, Kenilworth, N.J., USA in the United States and Canada (NYSE: MRK) – has opened the doors to its new Innovation and Development Hub in Zurich. The new MSD Zurich Hub at “The Circle” […]
MSD Merck Sharp & Dohme AG has appointed Dr Corinna Lenz as the new site manager of the Swiss research and development unit at Werthenstein BioPharma GmbH. Corinna Lenz is replacing Justin Pennington who occupied the role in a temporary capacity. Werthenstein BioPharma GmbH plays a key role in the global provision of new innovative […]
MSD Merck Sharp & Dohme announced on February 5, 2020, the spinoff of its women’s health, proven established brands and biosimilars businesses to a new independent company. The transaction is expected to be completed during Q2 of 2021. Organon & Co (Organon), the name of the new spin-off, has a strong brand value and is […]
New mobile working options boost agility at MSD Switzerland
The MSD (Merck Sharp & Dohme) group is implementing a new policy allowing more flexibility for home office. In future, each employee will be free to determine how much or how often they work remotely. The introduction of this policy derives from the company-wide initiative to create New Ways of Working, launched in 2018. A […]
https://www.msd.ch/en/news/new-mobile-working-options-boost-agility-at-msd-switzerland/